MetOx Accelerates US Manufacturing Expansion with Strategic Capital Infusion
This capital infusion is from a consortium of prominent strategic and financial investors.
- This capital infusion is from a consortium of prominent strategic and financial investors.
- Led by Koch Disruptive Technologies, this capital infusion enables MetOx to dramatically expand production of Xeus™ HTS
The investment, led by Koch Disruptive Technologies (KDT) and supported by Safar Partners, Piedmont Capital Investments, DNS Capital, and other investors, will enable MetOx to dramatically expand its domestic production capacity of Xeus™. - "Xeus wire is a critical technology for power generation, grid capacity expansion and numerous other applications such as advanced medical diagnostics.
- This financing will enable capacity expansion by an order of magnitude and further develop its technology with future products and advancements.